IDENIX PHARMACEUTICALS, INC. 9,393,416 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • November 16th, 2011 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York
The undersigned understands that you propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Idenix Pharmaceuticals, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by J.P. Morgan Securities LLC (the “Underwriter”), of common stock, $0.001 par value, of the Company (the “Securities”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.
